Price $2.60 |
Market Cap
331.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
0.02
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
301K
|
FCF
-1.5
|
|
Op. Margin
1.40%
|
Net Margin
-6.40%
|
ROE
66.70%
|
ROI
2.10%
|
|
ROA
-5.40%
|
EPS Growth
61.80%
|
Current Ratio
1.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| R1 RCM Inc (RCM) | $11.60 | - | - | 1.32B | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.38 | - | - | 56.6M | Strong Buy |
| Fulgent Genetics Inc (FLGT) | $6.09 | - | - | 106.5M | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $49.17 | - | - | 1.31B | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.64 | - | - | 44.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
